Related Experiment Video
Updated: Jul 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation
Eftihia Cocolakis1, Meiou Dai1, Loren Drevet1
1Hormones and Cancer Research Unit, Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec H3A 1A1, Canada.
Abstract:
Both the transforming growth factor-beta (TGFbeta)/Smad and the prolactin/JAK/STAT pathway are critical to the proper development, maintenance, and function of the mammary epithelial tissue. Interestingly, opposing physiological effects between these two signaling pathways are prominent in the regulation of mammary gland development. However, the exact nature of the biological network existing between the Smad and STAT signal transduction pathways has remained elusive. We identified a novel regulatory cross-talk mechanism by which TGFbeta-induced Smad signaling acts to antagonize prolactin-mediated JAK/STAT signaling and expression of target genes. Furthermore, we found activin, another member of the TGFbeta family, to also efficiently block STAT5 signaling and beta-casein expression in mammary epithelial cells. Our results indicate that ligand-induced activation of Smad2, -3, and -4 by activin and TGFbeta leads to a direct inhibition of STAT5 transactivation and STAT5-mediated transcription of the downstream target genes, beta-casein and cyclin D1, thereby blocking vital processes for mammary gland growth and differentiation. Finally, we unveiled the mechanism by which these two signaling cascades antagonize their effects, and we found that activated Smads inhibit STAT5 association with its co-activator CREB-binding protein, thus blocking STAT5 transactivation of its target genes and leading to inhibition of mammary gland differentiation and lactation.
Insights
Transforming growth factor-beta (TGFbeta)/Smad signaling antagonizes prolactin/JAK/STAT pathways in mammary glands. Activated Smads block STAT5 co-activator binding, inhibiting mammary gland growth and differentiation.
Area of Science:
- Cellular signaling pathways
- Mammary gland biology
- Molecular mechanisms of gene regulation
Background:
- The transforming growth factor-beta (TGFbeta)/Smad and prolactin/JAK/STAT pathways are crucial for mammary epithelial tissue development and function.
- Opposing roles of these pathways in mammary gland development are known, but their interaction remains unclear.
Purpose of the Study:
- To elucidate the regulatory cross-talk between Smad and STAT signaling pathways in mammary epithelial cells.
- To investigate how TGFbeta signaling influences prolactin-mediated JAK/STAT signaling.
- To understand the molecular basis of antagonism between these pathways.
Main Methods:
- Investigated the effects of TGFbeta and activin on JAK/STAT signaling in mammary epithelial cells.
- Analyzed the impact of Smad activation on STAT5 transactivation and target gene expression (beta-casein, cyclin D1).
- Examined the interaction between activated Smads, STAT5, and CREB-binding protein.
Main Results:
- TGFbeta-induced Smad signaling was found to antagonize prolactin-mediated JAK/STAT signaling.
- Activin and TGFbeta efficiently blocked STAT5 signaling and beta-casein expression.
- Activated Smads directly inhibited STAT5 transactivation by blocking its association with CREB-binding protein.
- This antagonism blocked mammary gland growth, differentiation, and lactation.
Conclusions:
- A novel cross-talk mechanism exists where Smad signaling inhibits JAK/STAT signaling in mammary epithelial cells.
- Smad activation blocks STAT5-mediated transcription of key genes like beta-casein and cyclin D1.
- This pathway interaction is critical for regulating mammary gland development, differentiation, and lactation.
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

